Insider · CIK 0001263508
BAKER BROS. ADVISORS LP
directorowner
Files at KALA (KALA BIO, Inc.), BGNE (BeiGene, Ltd.), BCYC (BICYCLE THERAPEUTICS PLC). First filing Dec 10, 2024, latest Dec 31, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
2 / 1
$23M bought, $194M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 42Moderate | buy | KALA KALA BIO, Inc. | $2.0M | 310,559 | +353% | - | |
| 50Moderate | buy | BCYC BICYCLE THERAPEUTICS PLC | $21M | 1,485,397 | +189% | - | |
| 75Notable | sell 3 | BGNE BeiGene, Ltd. | $194M | 1,037,017 | -118% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 30, 2024 | KALA KALA BIO, Inc. | POpen-market purchase Common Stockindirect: See Footnotes | +30,620 | $6.44 | $197k | 118,496 | Dec 31, 2024 |
| Dec 30, 2024 | KALA KALA BIO, Inc. | POpen-market purchase Common Stockindirect: See Footnotes | +279,939 | $6.44 | $1.8M | 1,083,398 | Dec 31, 2024 |
| Dec 13, 2024 | BCYC BICYCLE THERAPEUTICS PLC | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +2,809 | $13.50 | $38k | 790,763 | Dec 17, 2024 |
| Dec 13, 2024 | BCYC BICYCLE THERAPEUTICS PLC | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +30,241 | $13.50 | $408k | 8,666,247 | Dec 17, 2024 |
| Dec 13, 2024 | BCYC BICYCLE THERAPEUTICS PLC | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +5,573 | $13.63 | $76k | 796,336 | Dec 17, 2024 |
| Dec 13, 2024 | BCYC BICYCLE THERAPEUTICS PLC | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +59,995 | $13.63 | $818k | 8,726,242 | Dec 17, 2024 |
| Dec 13, 2024 | BCYC BICYCLE THERAPEUTICS PLC | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +22,722 | $13.72 | $312k | 819,058 | Dec 17, 2024 |
| Dec 13, 2024 | BCYC BICYCLE THERAPEUTICS PLC | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +244,587 | $13.72 | $3.4M | 8,970,829 | Dec 17, 2024 |
| Dec 13, 2024 | BCYC BICYCLE THERAPEUTICS PLC | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +52,656 | $13.80 | $727k | 871,714 | Dec 17, 2024 |
| Dec 13, 2024 | BCYC BICYCLE THERAPEUTICS PLC | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +566,814 | $13.80 | $7.8M | 9,537,643 | Dec 17, 2024 |
| Dec 16, 2024 | BCYC BICYCLE THERAPEUTICS PLC | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +42,369 | $15.34 | $650k | 914,083 | Dec 17, 2024 |
| Dec 16, 2024 | BCYC BICYCLE THERAPEUTICS PLC | POpen-market purchase American Depositary Sharesindirect: See Footnotes | +457,631 | $15.34 | $7.0M | 9,995,274 | Dec 17, 2024 |
| Dec 9, 2024 | BGNE BeiGene, Ltd. | SOpen-market sale American Depositary Sharesindirect: See Footnotes | -3,074 | $208.01 | $639k | 874,529 | Dec 10, 2024 |
| Dec 9, 2024 | BGNE BeiGene, Ltd. | SOpen-market sale American Depositary Sharesindirect: See Footnotes | -33,943 | $208.01 | $7.1M | 9,657,351 | Dec 10, 2024 |
| Dec 9, 2024 | BGNE BeiGene, Ltd. | SOpen-market sale American Depositary Sharesindirect: See Footnotes | -83,036 | $186.50 | $15M | 791,493 | Dec 10, 2024 |
| Dec 9, 2024 | BGNE BeiGene, Ltd. | SOpen-market sale American Depositary Sharesindirect: See Footnotes | -916,964 | $186.50 | $171M | 8,740,387 | Dec 10, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.